Market Place
Sourcing Support
All News #Library
Biotech
A2 Bio Gets FDA Fast Track for Logic-Gated CAR-T A2B543
01 Apr 2026 //
BUSINESSWIRE
A2 Bio Doses First Patient in EVEREST-2 Study with A2B543
26 Feb 2026 //
BUSINESSWIRE
A2 Biotherapeutics Clears FDA IND For A2B543
08 Jan 2026 //
BUSINESSWIRE
A2 Bio Presents Safety & Efficacy Data From EVEREST-2 Study
07 Nov 2025 //
BUSINESSWIRE
A2 Bio To Unveil EVEREST-2 Study Data At 2025 SITC Meeting
03 Oct 2025 //
BUSINESSWIRE
A2 Bio Shares Ph1/2 EVEREST-2 Study Data at Lung Cancer Meeting
08 Sep 2025 //
BUSINESSWIRE
A2 Bio Doses First Patient in DENALI-1 CAR T Study
26 Jun 2025 //
BUSINESSWIRE
A2 Biotherapeutics Secures $80M For Tmod™ Cell Therapy Platform
09 Jan 2025 //
BUSINESSWIRE
A2 Bio Highlights Tmod™ CAR T-Cell Progress at SITC 2024
09 Nov 2024 //
BUSINESS STD
A2 Bio To Present EVEREST-1 Trial Data At SITC Meeting
04 Oct 2024 //
BUSINESSWIRE
A2 Bio Announces First Patient Dosed in Phase 1 Clinical Trial of A2B530
30 May 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.